Clinical and Experimental Hepatology
eISSN: 2449-8238
ISSN: 2392-1099
Clinical and Experimental Hepatology
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
Share:
Send email
Share:
Original paper

Associations between diffusion-weighted imaging and immunohistochemical features in hepatocellular carcinoma: a preliminary analysis of tumor-infiltrating lymphocytes and microvessel density expression

Daniele Romeo
1, 2
,
Theresa Richter
1
,
Anne-Kathrin Höhn
3
,
Hans Michael Tautenhahn
4
,
Daniel Seehofer
4
,
Uwe Scheuermann
4
,
Timm Denecke
1
,
Hans-Jonas Meyer
1

  1. Department of Diagnostic and Interventional Radiology, University of Leipzig, Leipzig, Germany
  2. Department of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), University of Palermo, Palermo, Italy
  3. Department of Pathology, University of Leipzig, Leipzig, Germany
  4. Department of Visceral, Transplant, Thoracic and Vascular Surgery, University of Leipzig, Leipzig, Germany
Clin Exp HEPATOL 2025; 11, 4
DOI: https://doi.org/10.5114/ceh.2025.155477
Online publish date: 2025/11/13
Article file
- Associations.pdf  [0.20 MB]
Get citation
 
PlumX metrics:
 
1. Jiang HY, Chen J, Xia CC, et al. Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis. World J Gastroenterol 2018; 24: 2348-2362.
2. Ablefoni M, Richter T, Leonhardi J, et al. Potential diagnostic value of high b-value computed diffusion-weighted imaging in hepatocellular carcinoma. Clin Exp Hepatol 2024; 10: 129-136.
3. Cho ES, Choi JY. MRI features of hepatocellular carcinoma related to biologic behavior. Korean J Radiol 2015; 16: 449-464.
4. Le Bihan D. Apparent diffusion coefficient and beyond: what diffusion MR imaging can tell us about tissue structure. Radiology 2013; 268: 318-322.
5. Surov A, Meyer HJ, Wienke A. Correlation between apparent diffusion coefficient (ADC) and cellularity is different in several tumors: a meta-analysis. Oncotarget 2017; 8: 59492-59499.
6. Surov A, Meyer HJ, Wienke A. Associations between apparent diffusion coefficient (ADC) and KI 67 in different tumors: a meta-analysis. Part 1: ADCmean. Oncotarget 2017; 8: 75434-75444.
7. Surov A, Meyer HJ, Winter K, et al. Histogram analysis parameters of apparent diffusion coefficient reflect tumor cellularity and proliferation activity in head and neck squamous cell carcinoma. Oncotarget 2018; 9: 23599-23607.
8. Kim JG, Jang KM, Min GS, et al. Questionable correlation of the apparent diffusion coefficient with the histological grade and microvascular invasion in small hepatocellular carcinoma. Clin Radiol 2019; 74: 406.e19-406.e27.
9. Chen J, Wu Z, Zhang Z, et al. Apparent diffusion coefficient and tissue stiffness are associated with different tumor microenvironment features of hepatocellular carcinoma. Eur Radiol 2024; 34: 6980-6991.
10. Yang C, Wei XQ, Zheng J, et al. A correlative study between IVIM-DWI parameters and VEGF and MMPs expression in hepatocellular carcinoma. Quant Imaging Med Surg 2023; 13: 1887-1898.
11. Vernuccio F, Rosenberg MD, Meyer M, et al. Negative biopsy of focal hepatic lesions: decision tree model for patient management. AJR Am J Roentgenol 2019; 212: 677-685.
12. Colapietro F, Viganò M, Cerini F, et al. Incidence and predictors of complications following percutaneous liver biopsy: A large Italian multicentre study. Liver Int 2025; 45: e70078.
13. Kasurinen J, Hagström J, Kaprio T, et al. Tumor-associated CD3- and CD8-positive immune cells in colorectal cancer: The additional prognostic value of CD8+-to-CD3+ ratio remains debatable. Tumour Biol 2022; 44: 37-52.
14. Heo SH, Jeong YY, Shin SS, et al. Apparent diffusion coefficient value of diffusion-weighted imaging for hepatocellular carcinoma: correlation with the histologic differentiation and the expression of vascular endothelial growth factor. Korean J Radiol 2010; 11: 295-303.
15. Surov A, Pech M, Omari J, et al. Diffusion-weighted imaging reflects tumor grading and microvascular invasion in hepatocellular carcinoma. Liver Cancer 2021; 10: 10-24.
16. Hu XX, Yang ZX, Liang HY, et al. Whole-tumor MRI histogram analyses of hepatocellular carcinoma: Correlations with Ki-67 labeling index. J Magn Reson Imaging 2017; 46: 383-392.
17. Meyer HJ, Leonhardi J, Potratz J, et al. Association between radiomics of diffusion-weighted imaging and histopathology in hepatocellular carcinoma. A preliminary investigation. Magn Reson Imaging 2025; 118: 110356.
18. Surov A, Eger KI, Potratz J, et al. Apparent diffusion coefficient correlates with different histopathological features in several intrahepatic tumors. Eur Radiol 2023; 33: 5955-5964.
19. Piskin FC, Balli HT, Erdoğan KE, et al. Whole tumor volumetric ADC analysis: relationships with histopathological differentiation of hepatocellular carcinoma. Abdom Radiol (NY) 2021; 46: 5180-5189.
20. Kotsari M, Dimopoulou V, Koskinas J, Armakolas A. Immune system and hepatocellular carcinoma (HCC): New insights into HCC progression. Int J Mol Sci 2023; 24: 11471.
21. Feng H, Zhuo Y, Zhang X, et al. Tumor microenvironment in hepatocellular carcinoma: Key players for immunotherapy. J Hepatocell Carcinoma 2022; 9: 1109-1125.
22. Baghban R, Roshangar L, Jahanban-Esfahlan R, et al. Tumor microenvironment complexity and therapeutic implications at a glance. Cell Commun Signal 2020; 18: 59.
23. De Stefano F, Chacon E, Turcios L, et al. Novel biomarkers in hepatocellular carcinoma. Dig Liver Dis 2018; 50: 1115-1123.
24. Hiraoka N. Tumor-infiltrating lymphocytes and hepatocellular carcinoma: molecular biology. Int J Clin Oncol 2010; 15: 544-551.
25. Zheng X, Jin W, Wang S, Ding H. Progression on the roles and mechanisms of tumor-infiltrating T lymphocytes in patients with hepatocellular carcinoma. Front Immunol 2021; 12: 729705.
26. Gabrielson A, Wu Y, Wang H, et al. Intratumoral CD3 and CD8 T-cell densities associated with relapse-free survival in HCC. Cancer Immunol Res 2016; 4: 419-430.
27. Yao W, He JC, Yang Y, et al. The prognostic value of tumor-infiltrating lymphocytes in hepatocellular carcinoma: a systematic review and meta-analysis. Sci Rep 2017; 7: 7525.
28. Cui S, Hano H, Sakata A, et al. Enhanced CD34 expression of sinusoid-like vascular endothelial cells in hepatocellular carcinoma. Pathol Int 1996; 46: 751-756.
29. Pusztaszeri MP, Seelentag W, Bosman FT. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem 2006; 54: 385-395.
30. Yao S, Zhang J, Chen H, et al. Diagnostic value of immunohistochemical staining of GP73, GPC3, DCP, CD34, CD31, and reticulin staining in hepatocellular carcinoma. J Histochem Cytochem 2013; 61: 639-648.
31. Enan ET, El-Hawary AK, El-Tantawy DA, et al. Diagnostic role of glypican 3 and CD34 for differentiating hepatocellular carcinoma from nonmalignant hepatocellular lesions. Ann Diagn Pathol 2013; 17: 490-493.
32. Wang F, Jing X, Wang T, et al. Differential diagnostic value of GPC3-CD34 combined staining in small liver nodules with diameter less than 3 cm. Am J Clin Pathol 2012; 137: 937-945.
33. Swartz JE, Driessen JP, van Kempen PMW, et al. Influence of tumor and microenvironment characteristics on diffusion-weighted imaging in oropharyngeal carcinoma: A pilot study. Oral Oncol 2018; 77: 9-15.
34. Meyer HJ, Höhn AK, Surov A. Associations between ADC and tumor infiltrating lymphocytes, tumor-stroma ratio and vimentin expression in head and neck squamous cell cancer. Acad Radiol 2022; 29 Suppl 3: S107-S113.
35. Miyazaki K, Morine Y, Yamada S, et al. Stromal tumor-infiltrating lymphocytes level as a prognostic factor for resected intrahepatic cholangiocarcinoma and its prediction by apparent diffusion coefficient. Int J Clin Oncol 2021; 26: 2265-2274.
36. Xu J, Does MD, Gore JC. Dependence of temporal diffusion spectra on microstructural properties of biological tissues. Magn Reson Imaging 2011; 29: 380-390.
37. Murakami K, Kasajima A, Kawagishi N, et al. Microvessel density in hepatocellular carcinoma: Prognostic significance and review of the previous published work. Hepatol Res 2015; 45: 1185-1194.
38. Granito A, Galassi M, Piscaglia F, et al. Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study. Aliment Pharmacol Ther 2013; 37: 355-363.
39. Meyer HJ, Potratz J, Jechorek D, et al. Associations between dynamic-contrast enhanced MRI with histopathological features in atypical HCC using spatial co-registration with biopsy. Am J Transl Res 2025; 17: 2967-2975.
Copyright: © Clinical and Experimental Hepatology. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/) enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2025 Termedia Sp. z o.o.
Developed by Bentus.